[Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002128:Calcium Metabolism Disorders / Q000150:complications*; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D005116:Extrapyramidal Tracts; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D008745:Methylation; D009069:Movement Disorders / Q000378:metabolism*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010300:Parkinson Disease / Q000378:metabolism; D011748:Pyrogallol / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical; D013569:Synapses / Q000378:metabolism; D014191:Tranylcypromine / Q000494:pharmacology
D012702:Serotonin Antagonists; D011748:Pyrogallol; D014191:Tranylcypromine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D002118:Calcium; D004298:Dopamine; D009638:Norepinephrine
Contribution à l'étude du syndrome extrapyramidal en expérimentation animale: rôle du calcium et des dérivés o-méthylés.